Mike Desai

Co-Founder and CEO
Truentity Health
Raleigh / Chapel Hill, NC
Mike Desai 1

25+

Years in Leadership & Healthcare

2

Startups Initiated 

6,283

LinkedIn Followers

Mike’s Journey

Joined Ping Identity as VP of Global Channel Sales and Business Development.

2007

Joined xMatters as VP of Global Channel Sales & Alliances, formalizing and scaling the company’s global indirect sales channels.

2015

Became President of Airside, leading sales, marketing, and customer success for an identity and access management platform.

2019

2014

Founded The Desai Strategy Group as CEO, a boutique consulting firm specializing in go-to-market strategies and revenue growth for entrepreneurs and enterprises.

2016

Joined SecureAuth Corporation as EVP of International Sales and Corporate Development.

2020

Co-founded Truentity Health as CEO, transforming independent pharmacies into AI-powered clinical hubs for seniors with chronic conditions by leveraging frequent pharmacy touchpoints to identify risks, automate workflows, and deliver proactive care.

About Truentity Health

Founded - 2020 | Raleigh / Chapel Hill, NC | Stage - Series A

Highlight

Truentity Health helps pharmacies deliver chronic care, medication management, remote monitoring, and care coordination.

Problem

Patients with chronic conditions often interact with pharmacies more frequently than physicians, but pharmacies lack the clinical infrastructure to coordinate care at scale. Medication-related gaps and transitions of care create avoidable risk.

USP

Truentity turns local pharmacies into clinical care hubs. Its platform supports medication optimization, chronic care management, remote monitoring, and pharmacy-led care delivery, with a strategy aimed at Medicare, Medicaid, rural, and underserved communities.

Key Milestones

2020

Founded in North Carolina to build technology for older adults and people living with disabilities.

2022

Raised $1 million in pre-seed funding.

2024

Merged with IndyCare Health to strengthen pharmacy-led clinical care.

2026

Closed an oversubscribed $3.5 million Series A led by Evidenced VC.
Positioned the company to scale pharmacy-led clinical care nationwide.
In Their Own Words:

"Creating the most innovative clinical platform for pharmacies."